NEW YORK, June 15 (GenomeWeb News) - Iconix Pharmaceuticals will perform chemogenomics profiling and analysis services for Taisho Pharmaceutical of Japan, Mountain View, Calif.-based Iconix said today.

 

Under the agreement, Taisho will apply Iconix's DrugMatrix platform, a chemogenomics database, to help it select and optimize drug candidates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.